ArticleBreast cancer research and treatment2025

High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old.

Astrid Botty van den Bruele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.